the association between diabetes related medical costs and glycemic control a retrospective analysis糖尿病相关的医疗费用和血糖控制之间的关系进行回顾性分析.pdfVIP

Cost Effectiveness and Resource Allocation BioMed Central Research Open Access The association between diabetes related medical costs and glycemic control: A retrospective analysis Alan K Oglesby†1, Kristina Secnik†1, John Barron†2, Ibrahim Al-Zakwani†2 and Maureen J Lage*†3 Address: 1Eli Lilly and Company, Indianapolis, IN, USA, 2Healthcore, Inc., Wilmington, DE, USA and 3Healthmetrics Outcomes Research, Groton, CT, USA Email: Alan K Oglesby - oglesby_alan@; Kristina Secnik - secnik_kristina@; John Barron - jbarron@; Ibrahim Al-Zakwani - ial-zakwani@; Maureen J Lage* - lagemj@ * Corresponding author †Equal contributors Published: 16 January 2006 Received: 08 April 2005 Accepted: 16 January 2006 Cost Effectiveness and Resource Allocation 2006, 4:1 doi:10.1186/1478-7547-4-1 This article is available from: /content/4/1/1 © 2006 Oglesby et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The objective of this research is to quantify the association between direct medical costs attributable to type 2 diabetes and level of glycemic control. Methods: A longitudinal analysis using a large health plan administrative database was performed. The index date was defined as the first date of diabetes diagnosis and individuals had to have at least